Harpoon Therapeutics Stock
Harpoon Therapeutics is a preclinical stage biotechnology company.
Sign up today and learn more about Harpoon Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Harpoon Therapeutics Stock
Harpoon Therapeutics is a preclinical stage biotechnology company founded by MPM that is developing a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets.
William E. Picht
President & CEO
SENIOR VICE PRESIDENT
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase